NETEASE ($NTES) posted quarterly earnings results for Q4 2025 on Wednesday, February 11th. The company reported earnings of $10.85 per share, missing estimates of $14.48 by $3.63. The company also reported revenue of $27,222,028,202, missing estimates of $29,285,753,296 by $-2,063,725,094.
You can see Quiver Quantitative's $NTES stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
NETEASE Hedge Fund Activity
We have seen 211 institutional investors add shares of NETEASE stock to their portfolio, and 243 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 17,089,834 shares (+137821.2%) to their portfolio in Q3 2025, for an estimated $2,597,483,869
- HHLR ADVISORS, LTD. removed 872,861 shares (-52.5%) from their portfolio in Q3 2025, for an estimated $132,666,143
- ORBIS ALLAN GRAY LTD added 650,266 shares (+18.5%) to their portfolio in Q3 2025, for an estimated $98,833,929
- FMR LLC removed 644,031 shares (-37.8%) from their portfolio in Q3 2025, for an estimated $97,886,271
- BANK OF MONTREAL /CAN/ added 624,399 shares (+1636.4%) to their portfolio in Q3 2025, for an estimated $94,902,404
- DODGE & COX removed 453,200 shares (-16.5%) from their portfolio in Q3 2025, for an estimated $68,881,868
- CAPITAL INTERNATIONAL INVESTORS removed 318,890 shares (-55.4%) from their portfolio in Q3 2025, for an estimated $48,468,091
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
NETEASE Congressional Stock Trading
Members of Congress have traded $NTES stock 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $NTES stock by members of Congress over the last 6 months:
- REPRESENTATIVE JOSH GOTTHEIMER purchased up to $15,000 on 10/17.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 09/25 and 1 sale worth up to $15,000 on 10/14.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
NETEASE Analyst Ratings
Wall Street analysts have issued reports on $NTES in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Benchmark issued a "Buy" rating on 11/21/2025
- JP Morgan issued a "Overweight" rating on 10/10/2025
To track analyst ratings and price targets for NETEASE, check out Quiver Quantitative's $NTES forecast page.
NETEASE Price Targets
Multiple analysts have issued price targets for $NTES recently. We have seen 3 analysts offer price targets for $NTES in the last 6 months, with a median target of $158.0.
Here are some recent targets:
- Fawne Jiang from Benchmark set a target price of $158.0 on 11/21/2025
- Jiong Shao from Barclays set a target price of $135.0 on 11/21/2025
- Daniel Chen from JP Morgan set a target price of $190.0 on 10/10/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
